New treatment for severe hemophilia A
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests a new medicine called SKP-0141 to see if it can safely treat and prevent bleeding in people with severe hemophilia A. It might help reduce the number of bleeds and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a male between 12 and 65 years old.
- You must have severe hemophilia A, confirmed by a doctor.
- You must have used factor VIII products before (at least 150 times).
- If you can have children, you must agree to use birth control during the study and for 30 days after.
- You must not have a history of factor VIII inhibitors (a type of immune reaction).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called KN057 for people with hemophilia A or B, with or without inhibitors, to see if it helps prevent bleeding. It is for people who still have frequent bleeding episodes despite current treatments.
This trial tests a new gene therapy called SPK-8011QQ for adults with severe or moderately severe hemophilia A. The goal is to see if a single infusion can help your body produce its own factor VIII, reducing or stopping the need for regular factor VIII injections.
This study tests a new treatment (FRSW107) for severe hemophilia A in children under 12. It aims to see if this treatment is safe and helps prevent bleeding episodes.
This study tests whether KN057, a new preventive medicine, is safe for males with hemophilia A or B. It aims to help prevent bleeding episodes without causing unwanted blood clots.
This study tests a new medicine called SR604, given as a shot under the skin, to help prevent bleeding in people with hemophilia A or B. If it works, it could reduce the number of bleeding episodes and make daily life easier.
This trial tests a new injection called GS1191-0445 for people with hemophilia A. It aims to see if it is safe and works well to prevent or treat bleeding episodes.
Hear when a new Hemophilia A, Severe trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.